{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Inflammation", "Inflammatory bowel diseases", "Opioid receptors", "Opioids"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33394234", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "20"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1007/s11033-020-06095-x"], "Journal": {"ISSN": "1573-4978", "JournalIssue": {"Volume": "48", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jan"}}, "Title": "Molecular biology reports", "ISOAbbreviation": "Mol Biol Rep"}, "ArticleTitle": "Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations.", "Pagination": {"StartPage": "855", "EndPage": "874", "MedlinePgn": "855-874"}, "Abstract": {"AbstractText": ["Inflammatory bowel diseases (IBD) belong to a subgroup of persistent, long-term, progressive, and relapsing inflammatory conditions. IBD may spontaneously develop in the colon, resulting in tumor lesions in inflamed regions of the intestine, such as invasive carcinoma. The benefit of opioids for IBD treatment is still questionable, thereby we investigated databases to provide an overview in this context. This review demonstrates the controversial role of opioids in IBD therapy, their physiological and pharmacological functions in attenuating the IBD symptoms, and in improving inflammatory, oxidative stress, and the quality of life factors in IBD subjects. Data were extracted from clinical, in vitro, and in vivo studies in English, between 1995 and 2019, from PubMed, Google Scholar, Scopus, and Cochrane library. Based on recent reports, there are promising opportunities to target the opioid system and control the IBD symptoms. This study suggests a novel approach for future treatment of functional and inflammatory disorders such as IBD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Lashgari", "ForeName": "Naser-Aldin", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Roudsari", "ForeName": "Nazanin Momeni", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Zandi", "ForeName": "Nadia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Pazoki", "ForeName": "Benyamin", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Rezaei", "ForeName": "Atiyeh", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Hashemi", "ForeName": "Mehrnoosh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), and Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Gastrointestinal Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Rahimi", "ForeName": "Roja", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Shayan", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Dehpour", "ForeName": "Ahmad Reza", "Initials": "AR"}, {"Identifier": ["0000-0001-9961-9097"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), and Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "Gastrointestinal Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran. amirhosein172@hotmail.com."}], "LastName": "Abdolghaffari", "ForeName": "Amir Hossein", "Initials": "AH"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Biol Rep", "NlmUniqueID": "0403234", "ISSNLinking": "0301-4851"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Analgesics, Opioid"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Opioid"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Analgesics, Opioid"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": ["drug therapy", "genetics", "immunology", "pathology"], "DescriptorName": "Colitis, Ulcerative"}, {"QualifierName": ["drug therapy", "genetics", "immunology", "pathology"], "DescriptorName": "Crohn Disease"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "Intestines"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["psychology"], "DescriptorName": "Quality of Life"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Receptors, Opioid"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Perler B, Ungaro R, Baird G, Mallette M, Bright R, Shah S, Shapiro J, Sands BE (2019) Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort. BMC Gastroenterol 19(1):47. https://doi.org/10.1186/s12876-019-0963-7", "ArticleIdList": ["10.1186/s12876-019-0963-7", "30940072", "6446285"]}, {"Citation": "Burisch J, Munkholm P (2015) The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 50(8):942\u2013951", "ArticleIdList": ["25687629"]}, {"Citation": "Friedrich M, Pohin M, Powrie F (2019) Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity 50(4):992\u20131006", "ArticleIdList": ["30995511"]}, {"Citation": "Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14(5):329\u2013342", "ArticleIdList": ["24751956"]}, {"Citation": "Lashgari N-A, Roudsari NM, Momtaz S, Ghanaatian N, Kohansal P, Farzaei MH, Afshari K, Sahebkar A, Abdolghaffari AH (2020) Targeting mammalian target of rapamycin: prospects for the treatment of inflammatory bowel diseases. Curr Med Chem 27:1\u201320"}, {"Citation": "Halbmeijer N, Groeneweg M, De Ridder L (2019) Cannabis, a potential treatment option in pediatric IBD? Still a long way to go. Expert Rev Clin Pharmacol 12(4):355\u2013361", "ArticleIdList": ["30767696"]}, {"Citation": "Targownik LE, Nugent Z, Singh H, Bugden S, Bernstein CN (2014) The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis. Am J Gastroenterol 109(10):1613\u20131620", "ArticleIdList": ["25178702"]}, {"Citation": "Dasgupta N, Beletsky L, Ciccarone D (2018) Opioid crisis: no easy fix to its social and economic determinants. Am J Gastroenterol 108(2):182\u2013186"}, {"Citation": "Stein C (2016) Opioid receptors. Annu Rev Med 67:433\u2013451", "ArticleIdList": ["26332001"]}, {"Citation": "Veer AVT, Yano JM, Carroll FI, Cohen BM, Carlezon WA (2012) Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the \u03ba-opioid receptor antagonist JDTic. Neuropsychopharmacology 37(13):2809\u20132816"}, {"Citation": "Holzer P (2007) Treatment of opioid-induced gut dysfunction. Expert Opin Investig Drugs 16(2):181\u2013194", "ArticleIdList": ["17243938"]}, {"Citation": "Holzer P (2004) Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci Lett 361(1\u20133):192\u2013195", "ArticleIdList": ["15135926"]}, {"Citation": "Kato S, Tsuzuki Y, Hokari R, Okada Y, Miyazaki J, Matsuzaki K, Iwai A, Kawaguchi A, Nagao S, Itoh K (2005) Role of nociceptin/orphanin FQ (Noc/oFQ) in murine experimental colitis. J Neuroimmunol 161(1\u20132):21\u201328", "ArticleIdList": ["15748940"]}, {"Citation": "Toll L, Bruchas MR, Cox BM, Zaveri NT (2016) Nociceptin/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems. Pharmacol Rev 68(2):419\u2013457", "ArticleIdList": ["26956246", "4813427"]}, {"Citation": "Salaga M, Mokrowiecka A, Zielinska M, Malecka-Panas E, Kordek R, Kamysz E, Fichna J (2017) New peptide inhibitor of dipeptidyl peptidase IV, EMDB-1 extends the half-life of GLP-2 and attenuates colitis in mice after topical administration. J Pharmacol Exp Ther 363(1):92\u2013103", "ArticleIdList": ["28724693"]}, {"Citation": "Holzer P (2009) Opioid receptors in the gastrointestinal tract. Regul Pept 155(1-3):11\u201317", "ArticleIdList": ["19345246", "3163293"]}, {"Citation": "Collins S, Verma-Gandhu M (2006) The putative role of endogenous and exogenous opiates in inflammatory bowel disease. Gut 55(6):756\u2013757", "ArticleIdList": ["16698748", "1856222"]}, {"Citation": "Cozzi F, Podswiadek M, Cardinale G, Oliviero F, Dani L, Sfriso P, Punzi L (2007) Mud-bath treatment in spondylitis associated with inflammatory bowel disease\u2013a pilot randomised clinical trial. Jt Bone Spine 74(5):436\u2013439"}, {"Citation": "Philippe D, Chakass D, Thuru X, Zerbib P, Tsicopoulos A, Geboes K, Bulois P, Breisse M, Vorng H, Gay J (2006) Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. Gut 55(6):815\u2013823", "ArticleIdList": ["16299031", "1856226"]}, {"Citation": "Stefano G, Ptacek R, Kuzelova H, Kream R (2012) Endogenous morphine: up-to-date review 2011. Folia Biol 58(2):49\u201356"}, {"Citation": "Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P (2018) Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev 6:CD006332. https://doi.org/10.1002/14651858.CD006332.pub3", "ArticleIdList": ["10.1002/14651858.CD006332.pub3", "29869799"]}, {"Citation": "Boscan P, Van Hoogmoed LM, Farver TB, Snyder JR (2006) Evaluation of the effects of the opioid agonist morphine on gastrointestinal tract function in horses. Am J Vet Res 67(6):992\u2013997", "ArticleIdList": ["16740092"]}, {"Citation": "Peng X, Cebra JJ, Adler MW, Meissler JJ, Cowan A, Feng P, Eisenstein TK (2001) Morphine inhibits mucosal antibody responses and TGF-\u03b2 mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice. J Immunol 167(7):3677\u20133681", "ArticleIdList": ["11564781"]}, {"Citation": "Feng P, Rahim RT, Cowan A, Liu-Chen L-Y, Peng X, Gaughan J, Meissler JJ Jr, Adler MW, Eisenstein TK (2006) Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit. Eur J Pharmacol 534(1-3):250\u2013257", "ArticleIdList": ["16513108"]}, {"Citation": "Levran O, Yuferov V, Kreek MJ (2012) The genetics of the opioid system and specific drug addictions. Hum Genet 131(6):823\u2013842", "ArticleIdList": ["22547174", "3721349"]}, {"Citation": "Wei L-N, Loh HH (2011) Transcriptional and epigenetic regulation of opioid receptor genes: present and future. Annu Rev Pharmacol Toxicol 51:75\u201397", "ArticleIdList": ["20868272", "3681124"]}, {"Citation": "Ashenhurst JR, Bujarski S, Ray LA (2012) Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacol Biochem Behav 103(2):253\u2013259", "ArticleIdList": ["22954510", "3683577"]}, {"Citation": "Nalini Sehgal M, Howard Smith M, Laxmaiah Manchikanti M (2011) Peripherally acting opioids and clinical implications for pain control. Pain Physician 14:249\u2013258", "ArticleIdList": ["21587328"]}, {"Citation": "Wood JD, Galligan J (2004) Function of opioids in the enteric nervous system. J Neurogastroenterol Motil 16:17\u201328"}, {"Citation": "Poole DP, Pelayo JC, Scherrer G, Evans CJ, Kieffer BL, Bunnett NW (2011) Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice. Gastroenterology 141(3):982\u2013991", "ArticleIdList": ["21699782", "4429902"]}, {"Citation": "Donnerer J, Liebmann I (2009) Evidence for opioid-induced release of glutamate in guinea pig longitudinal muscle\u2013myenteric plexus strip. Neurosci Lett 462(2):118\u2013120", "ArticleIdList": ["19576952"]}, {"Citation": "De Luca A, Coupar IM (1996) Insights into opioid action in the intestinal tract. Pharmacol Ther 69(2):103\u2013115", "ArticleIdList": ["8984506"]}, {"Citation": "Brock C, Olesen SS, Olesen AE, Fr\u00f8kjaer JB, Andresen T, Drewes AM (2012) Opioid-induced bowel dysfunction. Drugs 72(14):1847\u20131865"}, {"Citation": "Nee J, Rangan V, Lembo A (2018) Reduction in pain: is it worth the gain? The effect of opioids on the GI tract. J Neurogastroenterol Motil 30(5):e13367"}, {"Citation": "Herman MA, Gillis RA, Vicini S, Dretchen KL, Sahibzada N (2011) Tonic GABAA receptor conductance in medial subnucleus of the tractus solitarius neurons is inhibited by activation of \u03bc-opioid receptors. J Neurophysiol 107(3):1022\u20131031", "ArticleIdList": ["22114164", "3289465"]}, {"Citation": "Herman MA, Alayan A, Sahibzada N, Bayer B, Verbalis J, Dretchen KL, Gillis RA (2010) \u03bc-Opioid receptor stimulation in the medial subnucleus of the tractus solitarius inhibits gastric tone and motility by reducing local GABA activity. Am J Physiol Gastrointest 299(2):G494\u2013G506"}, {"Citation": "Al-Hasani R, Bruchas MR (2011) Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115(6):1363\u20131381", "ArticleIdList": ["22020140", "3698859"]}, {"Citation": "Camilleri M, Lembo A, Katzka DA (2017) Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits. Clin Gastroenterol Hepatol 15(9):1338\u20131349", "ArticleIdList": ["28529168", "5565678"]}, {"Citation": "Moayyedi P, Andrews CN, MacQueen G, Korownyk C, Marsiglio M, Graff L, Kvern B, Lazarescu A, Liu L, Paterson WG (2019) Canadian association of gastroenterology clinical practice guideline for the management of irritable bowel syndrome (IBS). J Can Assoc Gastroenterol 2(1):6\u201329", "ArticleIdList": ["31294724", "6507291"]}, {"Citation": "Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L (2016) Eluxadoline for irritable bowel syndrome with diarrhea. N Engl J Med 374(3):242\u2013253", "ArticleIdList": ["26789872"]}, {"Citation": "Fabisiak A, Soboci\u0144ska M, Kamysz E, Fichna J, Zieli\u0144ska M (2018) Antinociceptive potency of enkephalins and enkephalinase inhibitors in the mouse model of colorectal distension\u2014proof-of-concept. Chem Biol Drug Des 92(1):1387\u20131392", "ArticleIdList": ["29495100"]}, {"Citation": "Szymaszkiewicz A, Storr M, Fichna J, Zielinska M (2019) Enkephalinase inhibitors, potential therapeutics for the future treatment of diarrhea predominant functional gastrointestinal disorders. J Neurogastroenterol Motil 31(4):e13526"}, {"Citation": "Zieli\u0144ska M, Jarmu\u017c A, Wasilewski A, Cami-Kobeci G, Husbands S, Fichna J (2017) Methyl-orvinol\u2014Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome. Pharmacol Rep 69(2):350\u2013357", "ArticleIdList": ["28187396"]}, {"Citation": "Pacifici R, di Carlo S, Bacosi A, Pichini S, Zuccaro P (2000) Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int Immunopharmacol 22(8):603\u2013614"}, {"Citation": "Fakhraei N, Javadian N, Rahimian R, Nili F, Rahimi N, Hashemizadeh S, Dehpour AR (2018) Involvement of central opioid receptors in protective effects of methadone on experimental colitis in rats. Inflammopharmacology 26(6):1399\u20131413", "ArticleIdList": ["30318564"]}, {"Citation": "Anselmi L, Huynh J, Duraffourd C, Jaramillo I, Vegezzi G, Saccani F, Boschetti E, Brecha N, De Giorgio R, Sternini C (2015) Activation of \u03bc opioid receptors modulates inflammation in acute experimental colitis. J Neurogastroenterol Motil 27(4):509\u2013523"}, {"Citation": "P-q Z, Fan H, Hu H, Tang Q, X-x L, L-j Z, Zhong M, Z-x S (2014) Role of DOR-\u03b2-arrestin1-Bcl2 signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis. J Huazhong Univ Sci Med 34(6):815\u2013820"}, {"Citation": "O\u2019Neil CK, Hanlon JT, Marcum ZA (2012) Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother 10(6):331\u2013342", "ArticleIdList": ["23036838", "3529168"]}, {"Citation": "Gross KJ, Pothoulakis C (2007) Role of neuropeptides in inflammatory bowel disease. Inflamm Bowel Dis 13(7):918\u2013932", "ArticleIdList": ["17343284"]}, {"Citation": "Lee N, Wald A (2012) Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation. Core Evidence 7:39\u201347", "ArticleIdList": ["22807692", "3396047"]}, {"Citation": "Bou\u00e9 J, Basso L, Cenac N, Blanpied C, Rolli-Derkinderen M, Neunlist M, Vergnolle N, Dietrich G (2014) Endogenous regulation of visceral pain via production of opioids by colitogenic CD4+ T cells in mice. Gastroenterology 146(1):166\u2013175", "ArticleIdList": ["24055279"]}, {"Citation": "Srinath AI, Walter C, Newara MC, Szigethy EM (2012) Pain management in patients with inflammatory bowel disease: insights for the clinician. Ther Adv Gastroenterol 5(5):339\u2013357"}, {"Citation": "Smith JP, Bingaman SI, Ruggiero F, Mauger DT, Mukherjee A, McGovern CO, Zagon IS (2011) Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn\u2019s disease: a randomized placebo-controlled trial. Dig Dis Sci 56(7):2088\u20132097", "ArticleIdList": ["21380937", "3381945"]}, {"Citation": "Mousavizadeh K, Rahimian R, Fakhfouri G, Aslani F, Ghafourifar P (2009) Anti-inflammatory effects of 5-HT3 receptor antagonist, tropisetron on experimental colitis in rats. Eur J Clin Investig 39(5):375\u2013383"}, {"Citation": "Khan N, Almukhtar R, Cole E, Abbas A (2014) Early corticosteroids requirement after the diagnosis of ulcerative colitis diagnosis can predict a more severe long-term course of the disease\u2013a nationwide study of 1035 patients. Aliment Pharmacol Ther 40(4):374\u2013381", "ArticleIdList": ["24961751"]}, {"Citation": "Gao Y, Liu X, Liu W, Qi Y, Liu X, Zhou Y, Wang R (2006) Opioid receptor binding and antinociceptive activity of the analogues of endomorphin-2 and morphiceptin with phenylalanine mimics in the position 3 or 4. Bioorg Med Chem Lett 16(14):3688\u20133692", "ArticleIdList": ["16682191"]}, {"Citation": "DiCello JJ, Saito A, Rajasekhar P, Eriksson EM, McQuade RM, Nowell CJ, Sebastian BW, Fichna J, Veldhuis NA, Canals M (2018) Inflammation-associated changes in DOR expression and function in the mouse colon. Am J Physiol Gastrointest Liver Physiol 315(4):G544\u2013G559", "ArticleIdList": ["29927325", "6230691"]}, {"Citation": "Fichna J, Dicay M, Lewellyn K, Janecka A, Zjawiony JK, MacNaughton WK, Storr MA (2011) Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors. Inflamm Bowel Dis 18(6):1137\u20131145", "ArticleIdList": ["21953882"]}, {"Citation": "Alt C, Lam JS, Harrison MT, Kershaw KM, Samuelsson S, Toll L, D\u2019andrea A (2012) Nociceptin/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis. Eur J Pharmacol 683(1-3):285\u2013293", "ArticleIdList": ["22449384", "6582657"]}, {"Citation": "Goldsmith JR, Perez-Chanona E, Yadav PN, Whistler J, Roth B, Jobin C (2013) Intestinal epithelial cell\u2013derived \u03bc-opioid signaling protects against ischemia reperfusion injury through PI3K Signaling. Am J Pathol 182(3):776\u2013785", "ArticleIdList": ["23291213", "3589074"]}, {"Citation": "Aguirre J, Winston J, Sarna S (2017) Neonatal immune challenge followed by adult immune challenge induces epigenetic-susceptibility to aggravated visceral hypersensitivity. J Neurogastroenterol Motil 29(9):e13081"}, {"Citation": "Zieli\u0144ska M, Haddou TB, Cami-Kobeci G, Sa\u0142aga M, Jarmu\u017c A, Padysz M, Kordek R, Spetea M, Husbands SM, Fichna J (2015) Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice. Eur J Pharmacol 765:582\u2013590", "ArticleIdList": ["26404500", "5064847"]}, {"Citation": "Tawfik DI, Osman AS, Tolba HM, Khattab A, Abdel-Salam LO, Kamel MM (2016) Evaluation of therapeutic effect of low dose naltrexone in experimentally-induced Crohn\u2019s disease in rats. Neuropeptides 59:39\u201345", "ArticleIdList": ["27392602"]}, {"Citation": "Reiss D, Ceredig R, Secher T, Bou\u00e9 J, Barreau F, Dietrich G, Gav\u00e9riaux-Ruff C (2017) Mu and delta opioid receptor knockout mice show increased colonic sensitivity. Eur J Pain 21(4):623\u2013634", "ArticleIdList": ["27748566"]}, {"Citation": "Matters GL, Harms JF, McGovern C, Fitzpatrick L, Parikh A, Nilo N, Smith JP (2008) The opioid antagonist naltrexone improves murine inflammatory bowel disease. J Immunotoxicol 5(2):179\u2013187", "ArticleIdList": ["18569389"]}, {"Citation": "Fakhraei N, Abdolghaffari AH, Delfan B, Abbasi A, Rahimi N, Khansari A, Rahimian R, Dehpour AR (2014) Protective effect of hydroalcoholic olive leaf extract on experimental model of colitis in rat: involvement of nitrergic and opioidergic systems. Phytother Res 28(9):1367\u20131373", "ArticleIdList": ["24590915"]}, {"Citation": "Kimball E, Prouty S, Pavlick K, Wallace N, Schneider C, Hornby P (2007) Stimulation of neuronal receptors, neuropeptides and cytokines during experimental oil of mustard colitis. J Neurogastroenterol Motil 19(5):390\u2013400"}, {"Citation": "Blennerhassett M, Lourenssen S, Parlow L, Ghasemlou N, Winterborn A (2017) Analgesia and mouse strain influence neuromuscular plasticity in inflamed intestine. J Neurogastroenterol Motil 29(10):1\u201312"}, {"Citation": "Kim H-Y, Hahm D-H, Pyun K-H, Lee S-K, Lee H-J, Nam T-C, Shim I (2005) Effects of acupuncture at GV01 on experimentally induced colitis in rats: possible involvement of the opioid system. Jpn J Physiol 55(3):205\u2013210", "ArticleIdList": ["15949059"]}, {"Citation": "Hiramoto K, Yamate Y, Sato EF (2016) The effects of ultraviolet eye irradiation on dextran sodium sulfate-induced ulcerative colitis in mice. Photochem Photobiol Sci 92(5):728\u2013734"}, {"Citation": "Sobczak M, Zakrzewski PK, Cygankiewicz AI, Mokrowiecka A, Chen C, Sa\u0142aga M, Ma\u0142ecka-Panas E, Kordek R, Krajewska WM, Fichna J (2014) Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases. Pharmacol Rep 66(5):741\u2013750", "ArticleIdList": ["25149976"]}, {"Citation": "Zhou J, Yang Y, Gan T, Li Y, Hu F, Hao N, Yuan B, Chen Y, Zhang M (2019) Lung cancer cells release high mobility group box 1 and promote the formation of neutrophil extracellular traps. Oncol Lett 18:181\u2013188", "ArticleIdList": ["31289487", "6540031"]}, {"Citation": "Kaneko K, Iwasaki M, Yoshikawa M, Ohinata K (2010) Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut \u03bc1-receptor coupled to 5-HT1A, D2, and GABAB systems. Am J Physiol Gastrointest Liver Physiol 299(3):G799\u2013G805", "ArticleIdList": ["20616303"]}, {"Citation": "Owczarek D, Cibor D, Mach T, Cie\u015bla A, Pierzcha\u0142a-Koziec K, Sa\u0142apa K, Ku\u015bnierz-Caba\u0142a B (2011) Met-enkephalins in patients with inflammatory bowel diseases. Adv Med Sci 56(2):158\u2013164", "ArticleIdList": ["22112433"]}, {"Citation": "Yu Y, Cui Y, Wang X, L-h L, Wang C-L, Y-z F, Liu J, Wang R (2007) In vitro characterization of the effects of endomorphin 1 and 2, endogenous ligands for \u03bc-opioid receptors, on mouse colonic motility. Biochem Pharmacol 73(9):1384\u20131393", "ArticleIdList": ["17274956"]}, {"Citation": "Breslow JM, Feng P, Meissler JJ, Pintar JE, Gaughan J, Adler MW, Eisenstein TK (2010) Potentiating effect of morphine on oral salmonella enterica serovar typhimurium infection is \u03bc-opioid receptor-dependent. Microb Pathog 49(6):330\u2013335", "ArticleIdList": ["20688146", "2956788"]}, {"Citation": "Fichna J, Dicay M, Hirota S, Traboulsi D, Macdonald J, Janecka A, Beck P, Zjawiony J, Macnaughton W, Storr M (2011) Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum. J Neurogastroenterol Motil 23(6):583\u2013e212"}, {"Citation": "Jim\u00e9nez-Vargas N, Rajasekhar P, Yeatman H, Canals M, Bunnett N, Poole D, Halls M, Reed D, Lomax A, Vanner S (2019) A27 the sustained antinociceptive effects of endogenous opioids in preclinical model of IBD is mediated by compartmentalized endosomal signaling by delta opioid receptors. J Can Assoc Gastroenterol 2:52\u201353", "ArticleIdList": ["6512542"]}, {"Citation": "Sobczak M, Pilarczyk A, Jonakowski M, Jarmu\u017c A, Sa\u0142aga M, Lipkowski AW, Fichna J (2014) Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases. Peptides 60:102\u2013106", "ArticleIdList": ["25151037"]}, {"Citation": "Guerrero-Alba R, Valdez-Morales EE, Jimenez-Vargas NN, Lopez-Lopez C, Jaramillo-Polanco J, Okamoto T, Nasser Y, Bunnett NW, Lomax AE, Vanner SJ (2017) Stress activates pronociceptive endogenous opioid signalling in DRG neurons during chronic colitis. Gut 66(12):2121\u20132131", "ArticleIdList": ["27590998"]}, {"Citation": "Noureldin M, Higgins PD, Govani SM, Cohen-Mekelburg S, Kenney BC, Stidham RW, Waljee JF, Waljee AK (2019) Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids. Aliment Pharmacol Ther 49(1):74\u201383", "ArticleIdList": ["30430615"]}, {"Citation": "Kuenzig E, Manuel D, Donelle J, Benchimol E (2019) A2 life expectancy in patients with inflammatory bowel disease (IBD); a population-based matched cohort study. J Can Assoc Gastroenterol 2:4\u20136", "ArticleIdList": ["6512233"]}, {"Citation": "Netzer P, Sendensky A, Wissmeyer M, Baumeler S, Batista C, Scheurer U, Krause T, Reber P, Brenneisen R (2008) The effect of naloxone-3-glucuronide on colonic transit time in healthy men after acute morphine administration: a placebo-controlled double-blinded crossover preclinical volunteer study. Aliment Pharmacol Ther 28(11\u201312):1334\u20131341", "ArticleIdList": ["18808445"]}, {"Citation": "Lie MR, van der Giessen J, Fuhler GM, de Lima A, Peppelenbosch MP, van der Ent C, van der Woude CJ (2018) Low dose Naltrexone for induction of remission in inflammatory bowel disease patients. J Transl Med 16(1):55. https://doi.org/10.1186/s12967-018-1427-5", "ArticleIdList": ["10.1186/s12967-018-1427-5", "29523156", "5845217"]}, {"Citation": "Fleyfel M, Dusson C, Ousmane M-L, Guidat A, Colombel J, Gambiez L, Vallet B (2008) Inflammation affects sufentanil consumption in ulcerative colitis. Eur J Anaesthesiol 25(3):188\u2013192", "ArticleIdList": ["17892611"]}, {"Citation": "Smith P, Dawson D, Swan C (1979) Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone. Gut 20(9):802\u2013805", "ArticleIdList": ["40848", "1412641"]}, {"Citation": "Sheehy KA, Lippold C, Rice AL, Nobrega R, Finkel JC, Quezado ZM (2017) Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study. J Pain Res 10:787", "ArticleIdList": ["28435316", "5388303"]}, {"Citation": "Zeitz J, Ak M, M\u00fcller-Mottet S, Scharl S, Biedermann L, Fournier N, Frei P, Pittet V, Scharl M, Fried M (2016) Pain in IBD patients: very frequent and frequently insufficiently taken into account. PLoS One 11(6):e0156666", "ArticleIdList": ["27332879", "4917102"]}, {"Citation": "Wang D (2017) Opioid medications in the management of chronic abdominal pain. Curr Pain Headache Rep 21(9):40", "ArticleIdList": ["28791598"]}, {"Citation": "Goldsmith JR, Kelly M, Freeman KB, Duro D (2015) Combined restitutive therapy for treatment of immunosuppressive refractory Crohn\u2019s Disease. J Pediatr Gastroenterol Nutr 60(4):e31", "ArticleIdList": ["24121152", "3981954"]}, {"Citation": "Sanford D, Thornley P, Teriaky A, Chande N, Gregor J (2014) Opioid use is associated with decreased quality of life in patients with Crohn\u2019s disease. Saudi J Gastroenterol 20(3):182", "ArticleIdList": ["24976282", "4067915"]}, {"Citation": "Podolsky DK (1991) Inflammatory bowel disease. N Engl J Med 325(14):1008\u20131016", "ArticleIdList": ["1886623"]}, {"Citation": "Smith JP, Field D, Bingaman S, Evans R, Mauger D (2013) Safety and tolerability of low dose naltrexone therapy in children with moderate to severe crohn\u2019s disease: a pilot study. J Clin Gastroenterol 47(4):339", "ArticleIdList": ["23188075", "3586944"]}, {"Citation": "Gregory MH, McKinnon A, Stwalley D, Hippensteel KJ, Loftus EV Jr, Ciorba MA, Olsen MA, Deepak P (2018) Anti-tumour necrosis factor therapy for inflammatory bowel diseases do not impact serious infections after arthroplasty. J Crohns Colitis 13(2):182\u2013188", "ArticleIdList": ["6548222"]}, {"Citation": "Cancienne JM, Patel KJ, Browne JA, Werner BC (2018) Narcotic use and total knee arthroplasty. J Arthroplast 33(1):113\u2013118"}, {"Citation": "Wren AA, Bensen R, Sceats L, Dehghan M, Yu H, Wong JJ, MacIsaac D, Sellers ZM, Kin C, Park K (2018) Starting young: trends in opioid therapy among US adolescents and young adults with inflammatory bowel disease in the Truven Marketscan database between 2007 and 2015. Inflamm Bowel Dis 24(10):2093\u20132103", "ArticleIdList": ["29986015", "6692855"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "23"}, {"Year": "2020", "Month": "12", "Day": "16"}, {"Year": "2021", "Month": "1", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "4", "Hour": "12", "Minute": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33394234", "10.1007/s11033-020-06095-x", "10.1007/s11033-020-06095-x"]}}], "PubmedBookArticle": []}